Josh Riggs
CIK 1956391 · CEO and President · last filed 2026-03-30
Josh Riggs is a CEO and President who has filed 9 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for OCX, was dated Mar 30, 2026. Across all open-market trades the lifetime net is +$10.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$10.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | CEO and President | 50,675 | $3.20 | $162.2K | $10.0K | 9 | 2026-03-30 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-30 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Mixed | +34,860 | -$50.6K | EDGAR |
| 2025-09-30 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-28 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-15 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +3,390 | $10.0K | EDGAR |
| 2023-08-17 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-28 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |